Screener
Boston Scientific BSX MedSurg — Operating Income (Loss), Adjusted
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept bsx:OperatingIncomeLossAdjusted.
The source filing: Boston Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 6:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885725-26-000033
| (in millions, except percentages) | Med Surg | % of Net Sales | Cardiovascular | % of Net Sales | Total |
|---|---|---|---|---|---|
| Selling, general and administrative expenses | 557 | 32.8% | 959 | 27.4% | |
| Research and development expenses | 127 | 7.5% | 343 | 9.8% | |
| Other segment items(1) | 5 | 0.3% | 7 | 0.2% | |
| Segment operating income(2) | 533 | 31.3% | 1,125 | 32.1% | 1,658 |
| Unallocated amounts: | |||||
| Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments | (199) | ||||
| Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs | (126) | ||||
| Amortization expense | (232) |
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Boston Scientific's medsurg — operating income (loss), adjusted?
- Boston Scientific (BSX) reported medsurg — operating income (loss), adjusted of $533M in Q1 2026.
- How has Boston Scientific's medsurg — operating income (loss), adjusted changed year-over-year?
- Boston Scientific's medsurg — operating income (loss), adjusted decreased by 0.6% year-over-year, from $536M to $533M.
- What is the long-term trend for Boston Scientific's medsurg — operating income (loss), adjusted?
- Over 3 years (2022 to 2025), Boston Scientific's medsurg — operating income (loss), adjusted has grown at a 15.2% compound annual growth rate (CAGR), from $1.49B to $2.28B.
- What does medsurg — operating income (loss), adjusted mean?
- Measures the profitability of the MedSurg segment by excluding non-recurring items, restructuring charges, and other adjustments from operating income. It provides a clearer view of the underlying operational performance and core earnings power of the MedSurg business.
Ask your AI about Boston Scientific's medsurg — operating income (loss), adjusted.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude